[1]
L. Pradelli, M. Calandriello, R. Di Virgilio, M. Bellone, and M. Tubaro, “The economic impact associated with cerebrovascular events related to non-valvular atrial fibrillation (NVAF) in Italy: the role of apixaban”, FE, vol. 15, no. 1S, pp. 3–4, Dec. 2014.